Standout Papers
Citation Impact
Citing Papers
Effects of Continuous Versus Cyclical Oral Contraception: A Randomized Controlled Trial
2007
Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus
2015
Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents
2015
Criteria, prevalence, and phenotypes of polycystic ovary syndrome
2016
Nonclassic Congenital Adrenal Hyperplasia
2010
Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone‐induced suppression
2002
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Distinctive Features of Female-to-Male Transsexualism and Prevalence of Gender Identity Disorder in Japan
2011
Puberty and Depression
2006
Glitazones and the management of insulin resistance: what they do and how might they be used
2004
Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndrome
2001
Three decades after Gjönnaess’s laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach
2013
Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study
2011
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
Thiazolidinediones
2004 Standout
Lack of an ovarian function influence on the increased adrenal androgen secretion present in women with functional ovarian hyperandrogenism
1997
What is polycystic ovary syndrome?: Are national views important?
2002
Microsatellite polymorphism (tttta)n at −528 base pairs of gene CYP11α influences hyperandrogenemia in patients with polycystic ovary syndrome
2000
Fetal Programming of Adrenal Androgen Excess: Lessons from a Nonhuman Primate Model of Polycystic Ovary Syndrome
2008
Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS
2001
A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: A pilot study
2004
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
2009
Polycystic Ovarian Morphology with Regular Ovulatory Cycles: Insights into the Pathophysiology of Polycystic Ovarian Syndrome
2004
Glucose-to-Insulin Ratio Rather than Sex Hormone-Binding Globulin and Adiponectin Levels Is the Best Predictor of Insulin Resistance in Nonobese Women with Polycystic Ovary Syndrome
2003
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
2008
Global health burden and needs of transgender populations: a review
2016 Standout
Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
2006
A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic Profile
1999
Follicle dynamics and anovulation in polycystic ovary syndrome
2008
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
2008
Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria
2007
The Relationship between C-Reactive Protein and Carotid Intima-Media Wall Thickness in Middle-Aged Women with Polycystic Ovary Syndrome
2004
Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
2005
DHEA and DHEA‐S: A Review
1999
What is polycystic ovarian syndrome?: A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome
2002
Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
2010
Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
2007
Diabetes Prevalence and Risk Factors in Polycystic Ovary Syndrome
2001
Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome
2014
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome
2008
Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
2011
Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome
2004
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus
2002
PCOS: a diagnostic challenge
2004
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
2007
The adrenal and polycystic ovary syndrome
2007
Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
2012
Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study
2002
Screening for Cushing’s syndrome in obese women with and without polycystic ovary syndrome
2003
The metabolic syndrome
2010 Standout
Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system
2012
Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
2001
Genetic and environmental aspect of polycystic ovary syndrome
2003
Dermatology of androgen-related disorders
2006
Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)
2005
Diagnosis and treatment of polycystic ovarian syndrome in adolescents
2012
High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome
2004
Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups
2005
Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome
2006
Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated
2004
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria
2012
Metformin for the Treatment of the Polycystic Ovary Syndrome
2008
Abnormal aminotransferase activity in women with polycystic ovary syndrome
2005
The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome
2009
Endocrine disrupting chemicals and disease susceptibility
2011
Polycystic ovary syndrome: Syndrome XX?
2003
Polycystic Ovary Syndrome in Adolescence
2008
Prevalencia de hiperandrogenismo y síndrome de ovario poliquístico en transexuales de mujer a hombre
2014
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study
2008
DHEA, DHEAS and PCOS
2014
The lack ofassociationbetween idiopathic hirsutism and metabolic disturbances: Iranian PCOS Prevalence Study
2013
Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome
2003
Defining hirsutism in Chinese women: a cross-sectional study
2011
The genetics of the polycystic ovary syndrome
2007
Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: A Mendelian randomization meta-analysis
2009
INSULIN ACTION IN THE POLYCYSTIC OVARY SYNDROME
1999
Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone
2005
Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study
2010
Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome
2011
Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome
2011
Polycystic Ovaries Are Common in Women with Hyperandrogenic Chronic Anovulation but Do Not Predict Metabolic or Reproductive Phenotype
2005
Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome
2008
Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
2006
Determinants of emotional distress in women with polycystic ovary syndrome
2006
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Adverse Effects of the Common Treatments for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
2013
Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large‐scale Chinese population
2009
Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization
2002
The role of metformin in polycystic ovary syndrome: a systematic review
2007
Aberrant Expression of Growth Differentiation Factor-9 in Oocytes of Women with Polycystic Ovary Syndrome
2002
Allelic Variants of the Follistatin Gene in Polycystic Ovary Syndrome1
2000
Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria
2014
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
A practical approach to the diagnosis of polycystic ovary syndrome
2004
The metabolic syndrome
2005 Standout
Degree of Facial and Body Terminal Hair Growth in Unselected Black and White Women: Toward a Populational Definition of Hirsutism
2006
Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome
2002
The Influence of Genetics and Environmental Factors in the Pathogenesis of Acne: A Twin Study of Acne in Women
2002
Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome
2005
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Selective Insulin Resistance in the Polycystic Ovary Syndrome1
1999
Heritability and the risk of developing androgen excess
1999
Effects of Race and Family History of Type 2 Diabetes on Metabolic Status of Women with Polycystic Ovary Syndrome
2005
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
2005
Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms
2003
The prevalence of androgen excess among patients with minimal unwanted hair growth
2004
8 Definition and significance of polycystic ovaries
1997
Treatment of the adolescent patient with polycystic ovary syndrome
2003
Heritability of Polycystic Ovary Syndrome in a Dutch Twin-Family Study
2006
Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization–embryo transfer
2005
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Prevalence of polycystic ovary syndrome in unselected women from southern China
2008
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Congenital adrenal hyperplasia
2005
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy
2003
Metformin administration improves endothelial function in women with polycystic ovary syndrome
2005
Acne vulgaris
2011 Standout
Insights into the Development of Polycystic Ovary Syndrome (PCOS) from Studies of Prenatally Androgenized Female Rhesus Monkeys
1998
The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase–deficient nonclassic adrenal hyperplasia
2009
Androgen excess is the key element in polycystic ovary syndrome
2003
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
2011
3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism
1993
Predictors of Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome
2005
Effects of Metformin on Early Pregnancy Loss in the Polycystic Ovary Syndrome
2002
A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome
2006
Increased risk of depressive disorders in women with polycystic ovary syndrome
2007
Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis
2004
Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin‐releasing hormone secretion
2009
Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity
2004
Enzymatic Activities of P450c17 Stably Expressed in Fibroblasts from Patients with the Polycystic Ovary Syndrome1
2000
Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?
2002
Hirsutism
2005
Depression in adolescence
2012 Standout
Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical, and Genetic Association Studies
2006
Current Approaches to the Diagnosis and Treatment of Polycystic Ovarian Syndrome in Youth
2007
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome
2007
Polycystic Ovary Syndrome
2005 Standout
Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome
2006
THE EPIDEMIOLOGY OF POLYCYSTIC OVARY SYNDROME
1999
A Risk-Benefit Assessment of Pharmacological Therapies for Hirsutism
2001
Adolescent Anovulation: Maturational Mechanisms and Implications
2013
Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents
2006
Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17α
1994
Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess
2002
Prevalence of 21-hydroxylase–deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico
2000
Molecular progress in infertility: polycystic ovary syndrome
2002
Polycystic Ovary Syndrome
2004
The investigation and management of hirsutism
2012
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
2005
Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility
2003
β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
2005
The Biology of Hair Follicles
1999 Standout
A Simple Screening Approach for Assessing Community Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka
2008
Inter- and intrafamilial variability in premature pubarche and polycystic ovary syndrome
2002
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing
2008
Androgen excess: Investigations and management
2016
The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome
2002
The Metabolic Syndrome in Polycystic Ovary Syndrome
2007
Insulin-Lowering Drugs In Polycystic Ovary Syndrome
2001
Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome
2003
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries
2009
Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal
2008
The evaluation and management of hirsutism*1
2003
Polycystic ovary syndrome
1997
Assessment and management of anovulatory infertility in polycystic ovary syndrome
2003
Polycystic Ovary Syndrome in the Adolescent
2009
Why do many psychiatric disorders emerge during adolescence?
2008 Standout
The effect of polycystic ovary syndrome on health-related quality of life
2003
The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance
2008
Recurrent miscarriage
2006 Standout
Oral Contraceptives and the Management of Hyperandrogenism–Polycystic Ovary Syndrome in Adolescents
2005
Identifying Children at Risk for Polycystic Ovary Syndrome
2006
Polycystic ovary syndrome
2016 Standout
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
Polycystic Ovary Syndrome in Adolescence
2005
Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management
2005
Troglitazone Improves Ovulation and Hirsutism in the Polycystic Ovary Syndrome: A Multicenter, Double Blind, Placebo-Controlled Trial1
2001
Basic Infertility Including Polycystic Ovary Syndrome
2008
Impaired β-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome
2004
Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS
2010
The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
2014
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents
2003
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
2012
Hirsutism and acne in polycystic ovary syndrome
2004
Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome
2002
Decreased Insulin Receptor (IR) Autophosphorylation in Fibroblasts from Patients with PCOS: Effects of Serine Kinase Inhibitors and IR Activators
2002
Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women
1999
Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
2008
Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study
2011
Characteristics of Adolescents Presenting to a Multidisciplinary Clinic for Polycystic Ovarian Syndrome
2009
Incretin levels in polycystic ovary syndrome
2008
Increased Prevalence of Obstructive Sleep Apnea Syndrome in Obese Women with Polycystic Ovary Syndrome1
2001
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms
2009
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
2009
A Study of the Hexose-6-Phosphate Dehydrogenase Gene R453Q and 11β-Hydroxysteroid Dehydrogenase Type 1 Gene 83557insA Polymorphisms in the Polycystic Ovary Syndrome
2005
Recent Advances in Acne Vulgaris Research: Insights and Clinical Implications
2008
Pre-eclampsia
2015 Standout
Birth weight in offspring of mothers with polycystic ovarian syndrome
2005
Birth Weight and Polycystic Ovary Syndrome in Adult Life: Is There a Causal Link?
2015
Randomized Placebo-Controlled Trial of Metformin for Adolescents With Polycystic Ovary Syndrome
2006
CLINICAL UPDATES IN HAIR
1997
Pregnancy outcome in women with PCOS and in controls matched by age and weight
2003
Long-term health consequences of PCOS
2002
Visually scoring hirsutism
2009
Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
2009
A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome
2004
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
2009 Standout
Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial1
2000
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
2008
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Obese Patients with Polycystic Ovary Syndrome: Evidence that Metformin Does Not Restore Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Ovarian Steroids
2003
Referral Bias in Defining the Phenotype and Prevalence of Obesity in Polycystic Ovary Syndrome
2013
Assessment, diagnosis and treatment of a patient with hirsutism
2008
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin
1999
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
2014
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess Society
2007
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment
2005
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
2014
The Association of Obesity and Hyperandrogenemia during the Pubertal Transition in Girls: Obesity as a Potential Factor in the Genesis of Postpubertal Hyperandrogenism
2006
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999
Regulation of Adiponectin Secretion by Adipocytes in the Polycystic Ovary Syndrome: Role of Tumor Necrosis Factor-α
2010
Polycystic Ovary Syndrome and Ovulation Induction
2007
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
2005
Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome
2003
Lifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
2013
Relationship of Calpain-10 Genotype to Phenotypic Features of Polycystic Ovary Syndrome
2002
Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy
2001
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Hormonal Profile of Women with Self-Reported Symptoms of Oligomenorrhea and/or Hirsutism: Northern Finland Birth Cohort 1966 Study
2003
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
1998
Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
2003
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
Obesity and PCOS: Implications for Diagnosis and Treatment
2012
Heritability of Insulin Secretion and Insulin Action in Women with Polycystic Ovary Syndrome and Their First Degree Relatives1
2001
Prevalence of Polycystic Ovary Syndrome in Women from Opposite-Sex Twin Pairs
2009
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Adrenal Function during Childhood and Puberty in Daughters of Women with Polycystic Ovary Syndrome
2009
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
miRNA-93 Inhibits GLUT4 and Is Overexpressed in Adipose Tissue of Polycystic Ovary Syndrome Patients and Women With Insulin Resistance
2013
A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence
2011
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Insertion of an intracisternal A particle within the 5'-regulatory region of a gene encoding folate-binding protein in L1210 leukemia cells in response to low folate selection. Association with increased protein expression.
1992 StandoutNobel
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
2006
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
2012
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Testosterone Measured by 10 Immunoassays and by Isotope-Dilution Gas Chromatography–Mass Spectrometry in Sera from 116 Men, Women, and Children
2003
Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals
2014
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
Failure of Mathematical Indices to Accurately Assess Insulin Resistance in Lean, Overweight, or Obese Women with Polycystic Ovary Syndrome
2004
Characterization of Functionally Typical and Atypical Types of Polycystic Ovary Syndrome
2009
Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
2012
Glucose Intolerance in a Large Cohort of Mediterranean Women With Polycystic Ovary Syndrome
2004
Interventions for hirsutism (excluding laser and photoepilation therapy alone)
2015
Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
2010
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
2005
The Importance of Diagnosing the Polycystic Ovary Syndrome
2000
Metformin Therapy in Obese Adolescents with Polycystic Ovary Syndrome and Impaired Glucose Tolerance: Amelioration of Exaggerated Adrenal Response to Adrenocorticotropin with Reduction of Insulinemia/Insulin Resistance
2002
The Metabolic Syndrome
2008 Standout
4: Polycystic ovary syndrome
2004
Adrenocortical Secretion of Dehydroepiandrosterone in Healthy Women: Highly Variable Response to Adrenocorticotropin
2001
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Folate-binding protein is a marker for ovarian cancer.
1991
Prevalence of Polycystic Ovary Syndrome Among Premenopausal Women With Type 2 Diabetes
2001
Prevalence of Nonalcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
2007
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome
2004
Genetic analysis of candidate genes for the polycystic ovary syndrome
2002
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
2012
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
2001
Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women
2000
High Prevalence of the Polycystic Ovary Syndrome and Hirsutism in Women with Type 1 Diabetes Mellitus1
2000
Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome
2007
The Value of the Low-Dose Dexamethasone Suppression Test in the Differential Diagnosis of Hyperandrogenism in Women
2003
Elevated Dehydroepiandrosterone Sulfate Levels as the Reproductive Phenotype in the Brothers of Women with Polycystic Ovary Syndrome
2002
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008 Standout
Genetics of the polycystic ovary syndrome
2012
Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
2003
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease in Young Women with Polycystic Ovary Syndrome
2006
Impact of Obesity on the Risk for Polycystic Ovary Syndrome
2007
Global Fibrinolytic Capacity Is Decreased in Polycystic Ovary Syndrome, Suggesting a Prothrombotic State
2002
Works of L.R. Boots being referenced
Adrenal androgen production in response to adrenocorticotropin infusions in men
1996
Ovulation After Glucocorticoid Suppression of Adrenal Androgens in the Polycystic Ovary Syndrome Is Not Predicted by the Basal Dehydroepiandrosterone Sulfate Level1
1999
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
2004
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1
1998 Standout
The Effects of Prolonged Hypertestosteronemia on Adrenocortical Biosynthesis in Oophorectomized Women*
1991
Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: A populational study
1999
Estrogen stimulation of conjugase activity in the uterus of ovariectomized rats
1975
Androgen Response to Hypothalamic-Pituitary-Adrenal Stimulation with Naloxone in Women with Myotonic Muscular Dystrophy
1998
Differential binding of estradiol and testosterone to SHBG. Relation to circulating estradiol levels.
1998
Ovulation After Glucocorticoid Suppression of Adrenal Androgens in the Polycystic Ovary Syndrome Is Not Predicted by the Basal Dehydroepiandrosterone Sulfate Level
1999
Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
1995
Adrenal Androgen Excess in the Polycystic Ovary Syndrome: Sensitivity and Responsivity of the Hypothalamic-Pituitary-Adrenal Axis1
1998
Cyclic variations in folate composition and pteroylpolyglutamyl hydrolase (conjugase) activity of the rat uterus
1976
Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation.
1995